Synapse Pharmatech is a finished-dose manufacturer based in India. It appears in 10 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), MINSA (CR) and UZPHARM (UZ). Its GMP standing is certified by CDSCO (India). Customs aggregates show $1.6M of exports covering 54 molecules to 7 destinations in 2025.
| Site | FDA FEI |
|---|---|
| ohio, United Arab Emirates | Not on file |
| dedhrota 383 220sabarkantha, India | Not on file |
| Village, India | Not on file |
| illage bhandutal visnagarmehsana 384 315, India | Not on file |
| ahmedabad 392 213, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 7 | None |
| MINSA (CR) | 1 | None |
| UZPHARM (UZ) | 1 | None |
| EDE (AE) | 1 | None |
| CDSCO (India) | None | 4 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $6K | 1 |
| 2025 | Not reported | $1.6M | 7 |
| 2024 | Not reported | $932K | 7 |
| 2023 | Not reported | $921K | 7 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Synapse Pharmatech comes back tiered against every other supplier able to file there.
Start for free